Guobang Pharma Ltd (605507) — Capital Reinvestment Ratio
Guobang Pharma Ltd (605507) has a Capital Reinvestment Ratio of 0.36x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥311.27 Million) in capital expenditures (CN¥110.58 Million). Check Guobang Pharma Ltd (605507) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guobang Pharma Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks Guobang Pharma Ltd's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see 605507 operating cash flow.
Annual Capital Reinvestment Ratio for Guobang Pharma Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for Guobang Pharma Ltd from 2017 to 2025. See Guobang Pharma Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.50x | CN¥559.28 Million | CN¥277.71 Million | ▼ -16.3% |
| 2024 | 0.59x | CN¥706.41 Million | CN¥419.12 Million | ▼ -59.0% |
| 2023 | 1.45x | CN¥516.76 Million | CN¥748.44 Million | ▲ +83.4% |
| 2022 | 0.79x | CN¥1.02 Billion | CN¥803.12 Million | ▲ +16.5% |
| 2020 | 0.68x | CN¥767.70 Million | CN¥520.16 Million | ▼ -50.6% |
| 2019 | 1.37x | CN¥440.86 Million | CN¥605.18 Million | ▲ +355.5% |
| 2018 | 0.30x | CN¥541.68 Million | CN¥163.24 Million | ▼ -73.7% |
| 2017 | 1.14x | CN¥148.03 Million | CN¥169.48 Million | — |